ALB and atrioventricular block: Of the 70 interviewed physicians (survey‐A) 6 (8.6%) reported not having access to endoscopic services for the treatment of AVB, whereas 79 of 88 (89.8%) interviewed physicians (survey‐B, question 1) reported having unrestricted access to albumin.